• Events
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • Legislative Policy Positions
    • State Actions & Resources
    • Policy Supported
  • Take Action
    • Take Action
    • We The Patients
    • Events
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • Legislative Policy Positions
    • State Actions & Resources
    • Policy Supported
  • Take Action
    • Take Action
    • We The Patients
    • Events
  • Donate

Tag: ICER

Patients Rising Now Sends Letter to EEOC on the QALY

Patients Rising Now Sends Letter to EEOC on the QALY

Feb 10, 2023 | Featured, QALY, Uncategorized

Patients Rising Now sent a letter to the Equal Employment Opportunity Commission (EEOC) regarding the release of its draft Strategic Enforcement Plan (SEP). The draft SEP outlined several new policy changes to enhance protections for employees from vulnerable...
Read more
Patients Rising Now Weighs in on House E&C QALY Hearing

Patients Rising Now Weighs in on House E&C QALY Hearing

Feb 2, 2023 | Featured Action, QALY

The House Energy and Commerce (E&C) Health Subcommittee held a hearing on banning the use of the Quality-Adjusted Life Year (QALY) in Federal health programs. The Protecting Health Care for All Patients Act (H.R.485) was recently reintroduced by Chairwoman Rodgers...
Read more
Patients Rising Now Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Relapsing Forms of Multiple Sclerosis

Patients Rising Now Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Relapsing Forms of Multiple Sclerosis

Nov 2, 2022 | ICER

On October 17, 2022, ICER released its draft evidence report, “Oral and Monoclonal Antibody Treatments for Relapsing Forms of Multiple Sclerosis.” This document provides a framework for considering what aspects of ICER’s review are important to people with multiple...
Read more
Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Menopause Vasomotor Symptoms

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Menopause Vasomotor Symptoms

Oct 25, 2022 | Featured, ICER, Uncategorized

On October 11, 2022, ICER released its draft evidence report, “Fezolinetant for Moderate to Severe Vasomotor Symptoms Associated with Menopause.” This document provides a framework for considering what aspects of ICER’s review are important to women and their...
Read more
Podcast 28: Empowering Chronic Disease in the Workplace

Podcast 28: Empowering Chronic Disease in the Workplace

Sep 5, 2020 | COVID-19, Featured

On this episode of the podcast, Terry and Bob discuss the prospects of a Covid-19 vaccine, which the whole nation, indeed the whole world, is waiting on with bated breath. The CDC has told states to be ready to distribute a vaccine by November. The letter notes that...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Coalitions
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Event
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Policy Supported
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • National Patient Group: White House’s War on Patients Harms Sick Americans
  • Letter to Senate Leadership Supporting PBM Reform from Employers & Other Stakeholders
  • Patients Rising Now Statement: ICER’s ‘Updates’ are Thinly Veiled Strategy to Continue Discriminatory Tactics
  • Patients Rising Now Issues Statement on E&C IRA Hearing
  • Patients Rising Now Signs onto Letter to Increase Patient Access to Pharmacy Services

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Events
  • We The Patients
  • Facebook
  • X
  • Instagram
All rights reserved. © 2023 Patients Rising Now